Mid American Wealth Advisory Group, Inc. Vaxcyte, Inc. Transaction History
Mid American Wealth Advisory Group, Inc.
- $210 Billion
- Q2 2025
A detailed history of Mid American Wealth Advisory Group, Inc. transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Mid American Wealth Advisory Group, Inc. holds 8,311 shares of PCVX stock, worth $342,496. This represents 0.13% of its overall portfolio holdings.
Number of Shares
8,311Holding current value
$342,496% of portfolio
0.13%Shares
1 transactions
Others Institutions Holding PCVX
# of Institutions
324Shares Held
139MCall Options Held
229KPut Options Held
160K-
Janus Henderson Group PLC London, X014.7MShares$605 Million0.25% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$494 Million0.01% of portfolio
-
Ra Capital Management, L.P. Boston, MA12MShares$493 Million8.5% of portfolio
-
Black Rock Inc. New York, NY9.94MShares$410 Million0.02% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6MShares$247 Million0.12% of portfolio
About Vaxcyte, Inc.
- Ticker PCVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,315,100
- Market Cap $2.44B
- Description
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...